Author

K. M. Campbell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

E. K. Barnell· 2 shared M. Griffith· 2 shared O. L. Griffith· 2 shared A. A. Chaudhuri· 1 shared A. Kalbasi· 1 shared A. R. Barnell· 1 shared A. Ribas· 1 shared D. E. Rugowski· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. K. Barnell

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintMar 30, 2020

Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach

K. M. Campbell, G. Steiner, D. K. Wells…·A. Kalbasi

The paper predicts SARS-CoV-2 peptide-HLA complexes across global populations and prioritizes epitopes for specific groups.

DOI 10.1101/2020.03.30.016931

humanproteomics

𝕏 PostBluesky

Cancer BiologyGastroenterologyPeer-reviewedSep 1, 2019

Stool-derived eukaryotic RNA biomarkers for detection of high-risk adenomas

E. K. Barnell, Y. Kang, A. R. Barnell…·O. L. Griffith

This study develops a stool-derived eukaryotic RNA biomarker model to detect high-risk adenomas and early-stage CRC with high sensitivity and specificity.

DOI 10.1053/j.gastro.2019.05.058

humanmetagenomics

𝕏 PostBluesky

Cancer BiologybioRxivOct 16, 2018

Spontaneous aggressive ERα+ mammary tumor model is driven by Kras activation

K. M. Campbell, K. A. O'Leary, D. E. Rugowski…·O. L. Griffith

This study identifies Kras activation as a driver of spontaneous ERα+ mammary tumors in a murine model, validated through genomic and transcriptomic analyses.

DOI 10.1016/j.celrep.2019.06.098

mousewhole-exome sequencing

𝕏 PostBluesky